Provided by Tiger Trade Technology Pte. Ltd.

Oncolytics Biotech Inc

0.5444
-0.0514-8.63%
Post-market: 0.55000.0056+1.03%19:58 EDT
Volume:1.12M
Turnover:624.20K
Market Cap:71.32M
PE:-1.69
High:0.6053
Open:0.6000
Low:0.5418
Close:0.5958
52wk High:1.36
52wk Low:0.5418
Shares:131.00M
Float Shares:126.58M
Volume Ratio:1.18
T/O Rate:0.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3215
EPS(LYR):-0.3000
ROE:-10187.64%
ROA:-211.24%
PB:-11.56
PE(LYR):-1.81

Loading ...

Analysts Offer Insights on Healthcare Companies: Stoke Therapeutics (STOK) and Oncolytics Biotech (ONCY)

TIPRANKS
·
Jul 14

Oncolytics Biotech to Meet FDA on Registrational Pathway for REO 033 Colorectal Cancer Trial

Reuters
·
Jul 13

Oncolytics Biotech - Half of Reo 33 Clinical Sites to be Activated This Month; over 20 Patients Pre-identified

THOMSON REUTERS
·
Jul 13

Oncolytics Biotech - to Hold Type D FDA Meeting on Reo 33 Registration Pathway

THOMSON REUTERS
·
Jul 13

Oncolytics Biotech - Initial Reo 33 Part a Tumor Response Update Expected by Year-end 2026; Part B Enrollment May Begin Q1 2027

THOMSON REUTERS
·
Jul 13

Oncolytics Biotech® Reports FDA Regulatory Milestone and Strong Clinical Progress in Randomized Ras-mutant Mss Colorectal Cancer Trial

THOMSON REUTERS
·
Jul 13

Oncolytics Biotech - Remaining Reo 33 Sites to be Activated by End of August for Accelerated Enrollment in H2 2026

THOMSON REUTERS
·
Jul 13

Oncolytics Biotech Swaps Auditor Ernst & Young for Baker Tilly

Reuters
·
Jul 09

Sector Update: Healthcare Stocks Advance in Afternoon Trading

MT Newswires Live
·
Jun 17

Oncolytics Gets US Patent for Pelareorep Manufacturing Process

MT Newswires Live
·
Jun 16

Oncolytics secures new patent for pelareorep manufacturing

TIPRANKS
·
Jun 16

Oncolytics Biotech wins new US manufacturing patent for pelareorep, protection through 2044

Reuters
·
Jun 16

Oncolytics Biotech - Announces New U.S. Patent for Pelareorep Manufacturing Process

THOMSON REUTERS
·
Jun 16

Oncolytics Biotech COO John Bearden McAdory files initial beneficial ownership statement

Reuters
·
Jun 04

Oncolytics Biotech director Stephen C. Glover files initial beneficial ownership statement

Reuters
·
Jun 04

Oncolytics promotes John McAdory to COO

TIPRANKS
·
Jun 02

Oncolytics Biotech® Announces Appointment of Steve Glover to Board of Directors and Promotion of John Mcadory to Chief Operating Officer

THOMSON REUTERS
·
Jun 02

Oncolytics announces initial data from pelareorep combination study

TIPRANKS
·
Jun 01

Oncolytics Says Preclinical Results Back Further Evaluation of Pelareorep Plus RAS-Targeted Approaches

MT Newswires Live
·
Jun 01

Oncolytics Biotech reports positive preclinical data for pelareorep with RAS-targeted therapies in solid tumor model

Reuters
·
Jun 01